A61K 47/6897
{Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies}
Currently, there are no issues on this topic.
Find more entities like A61K 47/6897
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.